Relevium Medical (YCS22)
@releviummed
Developing novel pharmacological hydrogel treatments for chronic pain conditions in urgent need of superior solutions.
ID: 1451165164095557637
http://www.relevium-medical.com 21-10-2021 12:35:26
30 Tweet
107 Takipçi
165 Takip Edilen
Twenty-five out of 42 new #EICTransition projects originated from research funded by the ERC. The new European Innovation Council grants will help take breakthrough technologies from the lab into the real world. 👉erc.europa.eu/news/erc-funde…
📢We are recruiting for the 2022-23 Fellowship starting in August 2022. CVs due before the end of February. To apply please submit your details and CV to bioinnovate.ie/fellowship-exp… More information nuigalway.ie/courses/taught… Stipend supported by Enterprise Ireland #medtech #PatientCare
NEWS: Relevium: Making a joint effort to tackle knee osteoarthritis The Irish Times irishtimes.com/news/science/r… Alison Liddy @barryj_mcd Garry P. Duffy
Proud to see Galway #Medtech innovator Alison Liddy CEO and Co-Founder Relevium Medical (YCS22) - a BioInnovate Ireland @nuigalway spin-out addressing #Osteoarthritis on this international HealthTech panel at EmTech Europe in Donegal today. #IU35Europe
Shout out from Alison Liddy to @IdeasLabNUIG and BioInnovate Ireland from the EmTech Europe #iu35europe stage! 👋 Lots of engines out there working together to drive innovation. (Hey, if you don’t know how to get plugged in, it’s cool, I’ll show you!)
Welcome to YC S22, @alisonliddy, @barryj_mcd, and team Relevium Medical (YCS22)! ReleviumBio is developing a pipeline of pharmacological peptide gel-based therapies, to address clinical areas where there is a need for long-lasting treatment effects: ycombinator.com/companies/rele…
Delighted to announce our 5th European Research Council (ERC) grant TMDLab (this time an ERC-Consolidator award). This 5-yr grant will focus on new disruptive treatments for chronic OA pain. Only possible via support from University of Galway Research & Innovation's medtech eco-system, We are now Research Ireland and @scienceirel
We are delighted to be nominated Ollscoil na Gaillimhe | University of Galway for the KTI Connect 'Future Forward Impact Award' with spin-out Relevium Medical (YCS22) who are working to reduce the burden of #ChronicPain
More good news from Ollscoil na Gaillimhe | University of Galway innovation: Fada Medical and Relevium Medical (YCS22) are both shortlisted for Big Ideas Enterprise Ireland Best of luck to @RobbieWylie and Alison Liddy in Croke Park next Thurs 24Nov22 #GlobalAmbition #bigideaslive22
The Commercialisation Award winner for 2022 is Dr Alison Liddy, Ollscoil na Gaillimhe | University of Galway Relevium Medical (YCS22) University of Galway Research & Innovation Read more about the 2022 SFI Awards: sfi.ie/research-news/… #SFISummit
Congrats Alison Liddy and the Relevium Medical (YCS22) team who are developing a novel, disruptive, treatment for #ChronicPain. Well-deserved recognition of this incredible spin-out.
Alison Liddy describes the injectable gel treatment designed by Relevium Medical (YCS22) to give superior relief and protection from knee osteoarthritis. The treatment targets specific pain sensing channels to provide more effective, rapid and long-lasting pain relief for osteoarthritis.
